[1] 刘万林,郭文通.激素性股骨头缺血性坏死动物模型诱导[J].内蒙古医科大学学报,1998(2):71-74.[2] 刘万林,郭文通,李文琪.激素性股骨头缺血坏死发病机理及其研究进展[J].中国矫形外科杂志,2000,7(2):169-172.[3] 刘万林,刘艳阳.激素性股骨头缺血坏死与前凝血状况的相关性研究[J].中华实验外科杂志,1999,16(4):377-377.[4] 白志刚,刘万林,苏秀兰,等.非创伤性股骨头坏死血管内皮生长因子mRNA与骨形态发生蛋白-2表达的研究[J].中华实验外科杂志, 2008,25(11):1528.[5] 刘万林,郝廷,冯卫,等.家兔激素性股骨头缺血坏死血管壁中差异表达基因的研究[J].中华创伤骨科杂志, 2008,10(11):1058-1061.[6] Zhu Y, Zhou J, Ao R, et al. A-769662 protects osteoblasts from hydrogen dioxide-induced apoptosis through activating of AMP-activated protein kinase (AMPK). Int J Mol Sci. 2014; 15(6):11190-11203. [7] Mikami T, Ichiseki T, Kaneuji A, et al. Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. J Orthop Sci. 2010;15(5):674-677. [8] Zhang C, Wang KZ, Qiang H, et al. Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo. Acta Pharmacol Sin. 2010;31(7):821-830.[9] McCormick J, Knight RA, Barry SP, et al. Autophagy in the stress-induced myocardium. Front Biosci (Elite Ed). 2012; 4:2131-2141.[10] Kim JN, Lee HS, Ryu SH, et al. Heat shock proteins and autophagy in rats with cerulein-induced acute pancreatitis. Gut Liver. 2011;5(4):513-520. [11] Klionsky DJ. Autophagy revisited: a conversation with Christian de Duve. Autophagy. 2008;4(6):740-743. [12] Thapalia BA, Zhou Z, Lin X. Autophagy, a process within reperfusion injury: an update. Int J Clin Exp Pathol. 2014; 7(12):8322-8341. [13] Chang YY, Neufeld TP. An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation. Mol Biol Cell. 2009;20(7):2004-2014. [14] 朱文胤,陈倩倩,刘祁,等.饥饿诱导下小鼠成骨细胞自噬与凋亡相互作用研究[J].川北医学院学报,2015(2):206-211.[15] Pattingre S, Espert L, Biard-Piechaczyk M, et al. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie. 2008;90(2):313-323. [16] Noda T, Matsunaga K, Taguchi-Atarashi N, et al. Regulation of membrane biogenesis in autophagy via PI3P dynamics. Semin Cell Dev Biol. 2010;21(7):671-676. [17] Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20(6):355-362. [18] Yamaguchi M, Noda NN, Nakatogawa H, et al. Autophagy-related protein 8 (Atg8) family interacting motif in Atg3 mediates the Atg3-Atg8 interaction and is crucial for the cytoplasm-to-vacuole targeting pathway. J Biol Chem. 2010;285(38):29599-29607. [19] Rosenfeldt MT, Ryan KM. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med. 2009; 11:e36. [20] Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287-1295.[21] Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214-226. [22] Fan QW, Cheng C, Hackett C, et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal. 2010;3(147):ra81. [23] Bunney TD, Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer. 2010;10(5): 342-352. [24] Li M, Zhao L, Liu J, et al. Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling. Cell Signal. 2010;22(10):1469-1476. [25] Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal. 2011;14(11):2201-2214.[26] Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy. 2007;3(1):28-31. [27] Crighton D, Wilkinson S, Ryan KM. DRAM links autophagy to p53 and programmed cell death. Autophagy. 2007;3(1):72-74. [28] O'Prey J, Skommer J, Wilkinson S, et al. Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy. Cell Cycle. 2009;8(14):2260-2265.[29] Barth S, Glick D, Macleod KF. Autophagy: assays and artifacts. J Pathol. 2010;221(2):117-124. [30] Ezaki J, Matsumoto N, Takeda-Ezaki M, et al. Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy. 2011;7(7):727-736.[31] Martinez J, Verbist K, Wang R, et al. The relationship between metabolism and the autophagy machinery during the innate immune response. Cell Metab. 2013;17(6):895-900. [32] Liu H, He Z, Simon HU. Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy. 2014; 10(2): 372-373.[33] Shapiro IM, Layfield R, Lotz M, et al. Boning up on autophagy: the role of autophagy in skeletal biology. Autophagy. 2014;10(1):7-19. [34] Nagao M, Feinstein TN, Ezura Y, et al. Sympathetic control of bone mass regulated by osteopontin. Proc Natl Acad Sci U S A. 2011;108(43):17767-17772. [35] Yanagita M. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev. 2005;16(3):309-317.[36] Gao C, Cao W, Bao L, et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol. 2010;12(8):781-790.[37] Chagin AS. Effectors of mTOR-autophagy pathway: targeting cancer, affecting the skeleton. Curr Opin Pharmacol. 2016;28:1-7. [38] Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143(5):813-825. [39] Sandri M, Barberi L, Bijlsma AY, et al. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology. 2013; 14(3):303-323.[40] Almeida M. Unraveling the role of FoxOs in bone--insights from mouse models. Bone. 2011;49(3):319-327.[41] Caramés B, Kiosses WB, Akasaki Y, et al. Glucosamine activates autophagy in vitro and in vivo. Arthritis Rheum. 2013;65(7):1843-1852. [42] Elefteriou F, Benson MD, Sowa H, et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 2006;4(6):441-451.[43] Kimura S, Fujita N, Noda T, et al. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol. 2009;452:1-12. [44] Levy JM, Thorburn A. Modulation of pediatric brain tumor autophagy and chemosensitivity. J Neurooncol. 2012;106(2): 281-290. [45] Han HE, Kim TK, Son HJ, et al. Activation of Autophagy Pathway Suppresses the Expression of iNOS, IL6 and Cell Death of LPS-Stimulated Microglia Cells. Biomol Ther (Seoul). 2013;21(1):21-28. [46] Monastyrska I, Rieter E, Klionsky DJ, et al. Multiple roles of the cytoskeleton in autophagy. Biol Rev Camb Philos Soc. 2009;84(3):431-448. [47] Youm YS, Lee SY, Lee SH. Apoptosis in the osteonecrosis of the femoral head. Clin Orthop Surg. 2010;2(4):250-255. [48] Eisenberg-Lerner A, Bialik S, Simon HU, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16(7):966-975. [49] 冯卫,刘万林,苏秀兰,等.激素性股骨头缺血坏死与血管壁中主要促血管生长因子生理活性关系的实验研究[J].中华创伤骨科杂志,2008,10(10):960-964.[50] Sarkar S, Korolchuk VI, Renna M, et al. Complex inhibitory effects of nitric oxide on autophagy. Mol Cell. 2011;43(1):19-32. [51] Viry E, Baginska J1, Berchem G1, et al. Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis. Autophagy. 2014;10(1):173-175. [52] Bai R, Zhao AQ, Zhao ZQ, et al. MicroRNA-195 induced apoptosis in hypoxic chondrocytes by targeting hypoxia-inducible factor 1 alpha. Eur Rev Med Pharmacol Sci. 2015;19(4):545-551.[53] 王文选.细胞凋亡与自噬在激素性股骨头缺血坏死中的作用机制研究进展[J].临床小儿外科杂志,2013,12(2):149-152.[54] Weinstein RS, Manolagas SC. Apoptosis in glucocorticoid -induced bone disease. Curr Opin Endocrinol Diabetes. 2005; 12(3):219-223.[55] Hotchkiss RS, Strasser A, McDunn JE, et al. Cell death. N Engl J Med. 2009;361(16):1570-1583. [56] Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease. Ann Intern Med. 1987;107(4):526-545.[57] Yao W, Cheng Z, Busse C, et al. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 2008;58(6):1674-1686. [58] Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006;21(3):466-476. [59] Xia X, Kar R, Gluhak-Heinrich J, et al. Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res. 2010;25(11): 2479-2488.[60] Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ. 2005;12 Suppl 2:1528-1534.[61] Gurusamy N, Das DK. Is autophagy a double-edged sword for the heart? Acta Physiol Hung. 2009;96(3):267-276. [62] Planey SL, Abrams MT, Robertson NM, et al. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res. 2003;63(1):172-178.[63] Bonapace L, Bornhauser BC, Schmitz M, et al. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest. 2010;120(4): 1310-1323. [64] Bohensky J, Shapiro IM, Leshinsky S, et al. HIF-1 regulation of chondrocyte apoptosis: induction of the autophagic pathway. Autophagy. 2007;3(3):207-214. [65] Alers S, Löffler AS, Wesselborg S, et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32(1):2-11. [66] Terkhorn SP, Bohensky J, Shapiro IM, et al. Expression of HIF prolyl hydroxylase isozymes in growth plate chondrocytes: relationship between maturation and apoptotic sensitivity. J Cell Physiol. 2007;210(1):257-265.[67] Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene. 2008;27 Suppl 1:S2-19. [68] Ryan KM. p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. Eur J Cancer. 2011;47(1):44-50.[69] 陈宝琅.激素性股骨头坏死发病机制中细胞凋亡的研究进展[J].中国当代医药,2016,23(19):12-15.[70] Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev. 2000;21(4):393-411.[71] Füllgrabe J, Klionsky DJ, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol. 2014;15(1):65-74. [72] Liu F, Fang F, Yuan H, et al. Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res. 2013;28(11):2414-2430. [73] Melkoumian ZK, Peng X, Gan B, et al. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res. 2005;65(15):6676-6684.[74] Ikebuchi K, Chano T, Ochi Y, et al. RB1CC1 activates the promoter and expression of RB1 in human cancer. Int J Cancer. 2009;125(4):861-867. [75] Martin N, Schwamborn K, Urlaub H, et al. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity. Mol Cell Biol. 2008; 28(8):2771-2781.[76] Ochi Y, Chano T, Ikebuchi K, et al. RB1CC1 activates the p16 promoter through the interaction with hSNF5. Oncol Rep. 2011;26(4):805-812. [77] Piemontese M, Onal M, Xiong J, et al. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone. Bone. 2015;75:18-26. [78] Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504-1508.[79] Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009 ;15(7):757-765. [80] Xian L, Wu X, Pang L, et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012;18(7):1095-1101. [81] Stenbeck G, Coxon FP. Role of vesicular trafficking in skeletal dynamics. Curr Opin Pharmacol. 2014;16:7-14.[82] DeSelm CJ, Miller BC, Zou W, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell. 2011;21(5):966-974. [83] Xiu Y, Xu H, Zhao C, et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Invest. 2014;124(1):297-310. [84] Lin NY, Chen CW, Kagwiria R, et al. Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss. Ann Rheum Dis. 2016;75(6):1203-1210.[85] Jia D, O'Brien CA, Stewart SA, et al. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology. 2006;147(12):5592-5599. [86] Jia J, Yao W, Guan M, et al. Glucocorticoid dose determines osteocyte cell fate. FASEB J. 2011;25(10):3366-3376. [87] Gao J, Cheng TS, Qin A, et al. Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes. Oncotarget. 2016;7(19): 26966-26978.[88] Dalle Carbonare L, Arlot ME, Chavassieux PM, et al. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001;16(1):97-103.[89] Yao W, Dai W, Jiang L, et al. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength. Osteoporos Int. 2016;27(1):283-294. |